胆代谢物,遗传易感性和意外心力衰竭
1Institute and Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
JACC. Advances
|January 10, 2025
概括
较高的总胆和脂胆水平与心力衰竭 (HF) 风险增加有关,而甘氨酸显示出一种保护性关联. 这些胆代谢物与HF风险有关,独立于遗传因素.
科学领域:
- 心血管医学 心血管医学
- 代谢学 代谢学 代谢学
- 遗传学 遗传学 是一个
背景情况:
- 胆代谢物 (总胆,脂胆,甘氨酸) 与心力衰竭 (HF) 发生率之间的关系尚不清楚.
- 调查这些关联对于识别HF的新风险因素和潜在治疗点至关重要.
研究的目的:
- 评估循环中的胆代谢物与发生心力衰竭 (HF) 之间的关联.
- 检查遗传敏感性是否会改变胆代谢物和高血压风险之间的关系.
主要方法:
- 一项针对245,072名英国生物库参与者 (2006-2010年至2023年) 的前性队列研究,在基线时没有心血管疾病.
- 使用核磁共振量化胆代谢物,并使用Cox比例危险模型分析发生的HF风险.
- 使用门德尔的随机化分析来调查潜在的因果关系.
主要成果:
- 在14.1年的时间里,确诊了5468例HF病例. 总胆和类胆与HF风险有积极的关联 (HR:每SD增加1.08).
- 甘氨酸与HF风险的反向关联 (HR:每SD增加0.97).
- 门德尔的随机化支持了总胆和甘氨酸与HF的潜在因果关系.
结论:
- 循环中的胆代谢物与发生性高血压风险有关,而不依赖于遗传倾向.
- 向胆代谢途径可能是改善心脏健康的未来策略,需要进一步验证.
相关概念视频
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Cholinergic Neurons: Neurotransmission
2.6K
Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
2.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Human Genetics
531
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
531
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95


